Search Results 241-250 of 14443 for Obesity/Overweight Treatment

  1. Weight loss: 6 strategies for success - Mayo Clinic

    ... overweight-obesity/health-risks. Accessed March 6, 2024. Jensen MD, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults ...

  2. Digestive Diseases Clinical Trials - Medical Professionals

    ... overweight or obese. Because it is a silent disease (without symptoms until end stage) and the lab tests can be normal, it can be missed in early stages. The ...

  3. Gastroenterology and Hepatology - Clinical trials

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment ... overweight or obese. Because it is a silent ...

  4. Humans With Obesity Response to Exercise - Mayo Clinic

    By condition, treatment or drug name. Search tips. Humans With Obesity Response to Exercise ... Fat tissue was once believed to be only important ... * Obese men ...

  5. Gastric fundal mucosal ablation targets hormonal causes of obesity - Mayo Clinic

    At Mayo Clinic, endoscopic sleeve gastroplasty (ESG) is used as an effective endoscopic therapy for patients seeking nonsurgical treatment for obesity.

  6. Metabolic and Abdominal Wall Reconstructive Surgery in Rochester - Clinical trials

    The purpose of this study is to evaluate the effectiveness and safety of endoscopic sleeve gastroplasty (ESG) for weight loss in a population of obese ...

  7. Bad Fat, Misbehaving Kidneys May Share Common Offender - Mayo Clinic News Network

    Understanding the difference may lead to therapies for metabolic disorders, obesity and potentially kidney disease. "We started this work by studying polycystic ...

  8. Removal of 'zombie cells' alleviates causes of diabetes in obese mice - Mayo Clinic News Network

    ... treatment of these conditions and their complications, which include diabetes,” says James Kirkland, M.D., Ph.D., senior author of the article. Dr. Kirkland ...

  9. Dietary Sugar Absorptive Phenotype for Prediction of Weight Loss Outcome - Mayo Clinic

    By condition, treatment or drug name ... Using stem cell derived intestinal epithelial cultures (enteroids) derived from obese (BMI> 30) patients and non-obese ...

  10. Early Feasibility of Endoscopic Gastric Mucosal Ablation (GMA) as a Primary Obesity Therapy - Mayo Clinic

    ... obesity-related comorbidity or BMI \> 40 to BMI ≤ 45). 2. Age 22 - 60 yrs. 3. Treatment naïve for bariatric surgery or endoscopic bariatric therapy 4 ...